http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2007500186-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/H01H23-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H15-04 |
| classificationIPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07B61-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07B53-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D309-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H15-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-70 |
| filingDate | 2004-11-15^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2007-01-11^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2007500186-A |
| titleOfInvention | 6R- (3,6-dideoxy-L-arabino-hexopyranosyloxy) heptanoic acid, its production method and its long-term dormancy-inducing effect |
| abstract | The present invention relates to the stereochemical structure of 6R- (3,6-dideoxy-L-arabino-hexopyranosyloxy) heptanoic acid, a pheromone secreted from sea elegance, related to aging and stress suppression, its synthesis and long-term Regarding dormancy-inducing effect. The present invention enables the development of drugs that use pheromones in connection with in vivo aging, stress, metabolic pathways and signal transduction systems and anti-cancer, obesity and aging, stress-inhibiting drugs. In addition, it will be possible to study the active target protein body of this pheromone. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2014522882-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11673908-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10479813-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10183963-B2 |
| priorityDate | 2004-02-05^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Showing number of triples: 1 to 57 of 57.